Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorder.
The Journal of Clinical Psychiatry April 1, 2011 DOI: 10.4088/jcp.10l06653 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | A patient with treatment-resistant obsessive-compulsive disorder |
| Intervention | Ketamine |
| Topics | Esketamine Ketamine |
| Key findings | A single patient with treatment-resistant OCD experienced rapid resolution of obsessions following an intravenous ketamine infusion, suggesting a potential fast-acting effect that warrants further study. |
Abstract
Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorder.
Comparable studies
Other case reports and case series on ketamine, most cited first.
Citations in the library
Cited by 18
- An update on ketamine and its two enantiomers as rapid-acting antidepressants Expert Review of Neurotherapeutics December 4, 2018
- Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature Brain Sciences June 27, 2021
- Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder Journal of Experimental Pharmacology 2021
- Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review Harvard Review of Psychiatry March 1, 2022
- A transdiagnostic systematic review and meta-analysis of ketamine’s anxiolytic effects medRxiv December 11, 2022
and 13 more in the library